Clinical Trial Update: Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase [Phase 4]

View source ↗

Summary

Phase 4 randomized, double-blind crossover study evaluating recombinant hyaluronidase pretreatment in two-way CSII treatment for Type 1 Diabetes Mellitus; compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Halozyme Therapeutics hyaluronidase (hyaluronidase)

Snippet

Sponsor: Halozyme Therapeutics | Conditions: Type 1 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2014-09-29